![]() Music |
![]() Video |
![]() Movies |
![]() Chart |
![]() Show |
![]() |
Case Study: Discovery of an early diagnostic biomarker for NASH (Sapient) View |
![]() |
Leveraging Pathophysiology and Context of Use to Identify NASH Clinical Trial Biomarkers (Celerion - Clinical Research) View |
![]() |
Non-Invasive Biomarkers of Metabolic Liver Disease (NIMBLE) (Foundation for the National Institutes of Health) View |
![]() |
Obeticholic acid reversed NASH liver fibrosis in phase 3 trial (MDedge: news and insights for busy physicians) View |
![]() |
ICE-HBV Serum Biomarkers Workshop - Biomarkers of Liver Cancer (ICE-HBV) View |
![]() |
Systematic Review of Syndrome Biomarkers in Metabolic Disorders Insights into Dysfunctions (Biology) View |
![]() |
Surgical Treatment of NAFLD (AmCollege Gastro) View |
![]() |
Innovative Radiology (Perspectum) View |
![]() |
Quantitative MRI predicts individual future liver performance after liver resection for cancer (Perspectum) View |
![]() |
Big data vs. the individual liver - regulatory perspective | Robert Schuck, PharmD, PhD (Academic Medical Education) View |